The Atlantic started the "Covid Tracking Project" when they had a great villain -- Donald Trump -- who they could beat over the head. They, along with the rest of the media, participated in hiding the Cuomo nursing home deaths, never investigating and never caring. Ditto for those in Michigan, New Jersey and Pennsylvania. There was not one complaint about banning drugs from being used against Covid-19, even though off-label prescriptions have been explicitly legal since the FDA was founded.
Nor was there a single complaint from any of these so-called "journalists" about the fact that myriad "non profit" entities, from Gates' evil spawn to the NIH and CDC to Vanderbilt to Johns Hopkins to many others all did not spend a single nickel running the data through a quick screen for all reasonably safe pharmaceutical and nutritional substances and then performing clinical trials with informed consent on those that might work.
And let me be clear: This is not by any means limited to The Atlantic; it stretches across the entirety of "organized journalism", all of which had a hard-on for Trump and was willing to destroy the economy, the education of children and watch your grandmother choke to death in order to "get" him.
We knew by summer that several inexpensive means of interdiction of this disease existed and did work -- specifically, HCQ + Zinc + {Z-Pak/Doxycycline}, Ivermectin and Vitamin D. Vitamin D deficiency turns out to be wildly associated with serious and fatal Covid-19 outcomes -- and is both disturbingly common and very easy to correct. Indeed, that association is so strong that had we put an effort into correcting that for pennies we might have prevented half or more of all the deaths with that single step alone.
We knew that certain others had failed, and for still more there was conflicting information -- for example while very high dose IV Vitamin C might work in certain cases it was not effective in reasonably-usable oral amounts.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.